132 related articles for article (PubMed ID: 11409712)
1. Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.
Dasí F; Benet M; Crespo J; Crespo A; Aliño SF
J Mol Med (Berl); 2001 May; 79(4):205-12. PubMed ID: 11409712
[TBL] [Abstract][Full Text] [Related]
2. Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors.
Crepso J; Blaya C; Crespo A; Aliño SF
Biochem Pharmacol; 1996 May; 51(10):1309-14. PubMed ID: 8787546
[TBL] [Abstract][Full Text] [Related]
3. Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vector.
Aliño SF
Biochem Pharmacol; 1997 Jul; 54(1):9-13. PubMed ID: 9296345
[TBL] [Abstract][Full Text] [Related]
4. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
[TBL] [Abstract][Full Text] [Related]
5. Asialofetuin liposomes for receptor-mediated gene transfer into hepatic cells.
Aliño SF; Benet M; Dasí F; Crespo J
Methods Enzymol; 2003; 373():399-421. PubMed ID: 14714418
[No Abstract] [Full Text] [Related]
6. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
Arangoa MA; Düzgüneş N; Tros de Ilarduya C
Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA.
Aliño SF; Crespo A; Dasí F
Gene Ther; 2003 Sep; 10(19):1672-9. PubMed ID: 12923566
[TBL] [Abstract][Full Text] [Related]
8. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP
Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389
[TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration.
Song YK; Liu F; Chu S; Liu D
Hum Gene Ther; 1997 Sep; 8(13):1585-94. PubMed ID: 9322091
[TBL] [Abstract][Full Text] [Related]
11. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
12. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
13. Preparation and disposition of asialofetuin-labelled liposome.
Tsuchiya S; Aramaki Y; Hara T; Hosoi K; Okada A
Biopharm Drug Dispos; 1986; 7(6):549-58. PubMed ID: 2435334
[TBL] [Abstract][Full Text] [Related]
14. Characterization, stability and in-vivo distribution of asialofetuin glycopeptide incorporating DSPC/CHOL liposomes prepared by mild cholate incubation.
Kallinteri P; Liao WY; Antimisiaris SG; Hwang KH
J Drug Target; 2001 Apr; 9(2):155-68. PubMed ID: 11697109
[TBL] [Abstract][Full Text] [Related]
15. Standardization of procedure for efficient ex vivo gene transfer into porcine pancreatic islets with cationic liposomes.
Benhamou PY; Moriscot C; Prevost P; Rolland E; Halimi S; Chroboczek J
Transplantation; 1997 Jun; 63(12):1798-803. PubMed ID: 9210507
[TBL] [Abstract][Full Text] [Related]
16. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
Díez S; Navarro G; de ILarduya CT
J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
[TBL] [Abstract][Full Text] [Related]
17. Variables affecting in vivo performance of high-capacity adenovirus vectors.
Schiedner G; Hertel S; Johnston M; Biermann V; Dries V; Kochanek S
J Virol; 2002 Feb; 76(4):1600-9. PubMed ID: 11799154
[TBL] [Abstract][Full Text] [Related]
18. α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.
Shahaf G; Moser H; Ozeri E; Mizrahi M; Abecassis A; Lewis EC
Mol Med; 2011; 17(9-10):1000-11. PubMed ID: 21670848
[TBL] [Abstract][Full Text] [Related]
19. Proteins and peptides bound to long-circulating liposomes.
Maruyama K; Mori A; Bhadra S; Subbiah MT; Huang L
Biochim Biophys Acta; 1991 Nov; 1070(1):246-52. PubMed ID: 1721540
[TBL] [Abstract][Full Text] [Related]
20. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
Riu E; Grimm D; Huang Z; Kay MA
Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
